Pharmaceuticals
Medikamente in der Tumortherapie
Medikamente in der Tumortherapie
Astrazeneca År 2006 | PDF
HORMONSKO ZDRAVLJENJE RAKA
Årsredovisning med information från Form 20-F 2005
DE69636531T2 - METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOVERABILITY OF PHARMACEUTICALS - Google Patents
Swissmedic Journal 12-2013_3
DE69636531T2 - METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOVERABILITY OF PHARMACEUTICALS - Google Patents
HORMONSKO ZDRAVLJENJE RAKA
Pharmaceuticals
A14-01 - Trastuzumab Emtansin - Nutzenbewertung gemäß § 35a SGB V
Exemestan Sandoz Drag 25 mg 90 Stk
oricând facultate dă jos ادوات للمطبخ شوك وملاعق inghetata Relativ mamifer
Teva-cyproterone/ethinyl estradiol - Uses, Side Effects, Interactions - MedBroadcast.com
Aromasin Drag 25 mg 100 Stk
Name Wirkstoff(e) ATC 4-DMAP Amp. Antidot-Lsg. 4 ...
Innovationsreport 2019
ZBIRNI POPIS OBJAVLJENIH CIJENA LIJEKOVA za 2020. godinu Datum zadnje dopune 27.06.2021.
S3-Leitlinie Endometriumkarzinom
Dossier zur Nutzenbewertung gemäß § 35a SGB V
Swissmedic Journal 12-2013_3
